BROADCASTS.com

She started with Slate Pharmaceuticals, which redefined long acting testosterone treatment for men then moved to Sprout Pharmaceuticals which broke through with the first ever FDA-approved drug for low sexual desire in women \u2014 dubbed \u201cfemale Viagra\u201d by the media. After selling the company for $1B in 2015, she successfully fought to get the drug back and launch it on her own terms. Meet Cindy Eckert!\nAddyi - Filbanserin - The first FDA approved medication to treat the condition Hypoactive (low) Sexual Desire Disorder (HSDD), characterized as frustrating low libido, is the most common form of sexual dysfunction in premenopausal women. Though not fully understood, HSDD is believed to be caused by an imbalance of chemicals in the brain.\nAre we limiting women by \u201cprotecting them\u201d?\nHow did Addyi come into her life?\nData on Addyi and breast cancer is coming out!\nPrescription versus supplements and what is \u201cnatural\u201d?\nYou make it look glam \u2013 but is it a slog?\nShe wants to make 1 Billion of wealth for women!\n\u201cSuccess comes from courage\u201d \u2013 Cindy Eckert. \nhttps://addyi.com\nhttps://thepinkceiling.com\nhttps://www.instagram.com/cindypinkceo/\nhttps://www.youtube.com/watch?v=DyuSZ80-kZI\nLove these interviews? Want to join them live with me? https://www.kellycaspersonmd.com/membership\nOur podcast sponsor is Bonafide\nBonafide products help women embrace the natural changes that occur throughout all phases of life.\nDiscount code for 20% off:NOTBROKEN\nSales link: https://hellobonafide.com/notbroken\n\n--- \n\nSend in a voice message: https://podcasters.spotify.com/pod/show/kj-casperson/message\nLearn more about your ad choices. Visit megaphone.fm/adchoices